X
28Jun

[Audio] Episode 148 -- A Review of the Novartis and Alcon FCPA Enforcement Action

Even during this difficult time of the pandemic, economic uncertainty and social unrest, the Justice Department and the SEC have concluded a major FCPA enforcement action. Novartis and Alcon (which was a Novartis subsidiary at the time of the misconduct) agreed to pay a total of $345 million in criminal and civil penalties. Novartis spun off Alcon in 2019. Under the DOJ settlement, Novartis and Alcon each entered into a deferred prosecution agreement; Novartis agreed to pay a fine of $225...
By: Michael Volkov
Source Url: https://www.jdsupra.com/legalnews/episode-148-a-review-of-the-novartis-40216/

Related

OSHA Enforcement for Respirable Crystalline Silica in Construction Standard, 2018-2019: By the Numbers

For construction employers anxious over how the Occupational Safety and Health Administration (OSHA)...

Read More >

ESG Disclosures: Lessons Learned and Best Practices [Part 3 of 4]

In our previous alert, we described the sustainability reporting ecosystem shaping the disclosure pa...

Read More >

[Video] FCPA Compliance Report-Episode 498 – Jay Rosen on Changes from the Compliance Vendor Perspective

The FCPA Compliance Report is the longest running podcast in compliance, premiering on July 31, 2015...

Read More >

Breaking The ICE: How Employers Can Push Back Against Punitive I-9 Fines

Climate change may make our summers hotter, but the ICEman still cometh. Since late 2017, Immigratio...

Read More >

U.K. Competition & Markets Authority Publishes Important Brexit Guidance

In anticipation of the United Kingdom’s exit from the EU on December 31 (‘Brexit’), the Competiti...

Read More >

Post-Creation Letter Exchange Doesn’t Constitute Work for Hire Agreement

Addressing an issue of whether a letter exchange qualifies as a work for hire agreement under US cop...

Read More >